Neovia Starts Enrollment in Phase 1 Immunotherapy Trial for Advanced Cancers – Immuno-Oncology News
Immuno-Oncology News |
Neovia Starts Enrollment in Phase 1 Immunotherapy Trial for Advanced Cancers
Immuno-Oncology News The first-in-human Neovia Oncology Phase 1 trial (NCT02797795) assessing the safety and effectiveness of the investigational drug NEV-801 in advanced cancers has enrolled its first patient. NEV-801 is a new multi-inhibitor drug meant to enhance … |
